4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
6.31
+0.53 (9.17%)
At close: Dec 20, 2024, 4:00 PM
6.62
+0.31 (4.91%)
After-hours: Dec 20, 2024, 4:16 PM EST
4D Molecular Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -143.48 | -100.84 | -107.49 | -71.32 | -56.69 | -49.31 | |
| Depreciation & Amortization | 6.43 | 5.75 | 3.88 | 3.02 | 1.44 | 1 | |
| Other Amortization | - | - | - | - | - | 2.61 | |
| Loss (Gain) From Sale of Assets | - | - | - | - | - | 0.01 | |
| Asset Writedown & Restructuring Costs | - | - | - | - | - | 5.14 | |
| Loss (Gain) From Sale of Investments | -5.81 | -1.24 | 1.06 | 0.72 | - | - | |
| Stock-Based Compensation | 24.54 | 19.75 | 17.21 | 13.89 | 5.03 | 3.54 | |
| Other Operating Activities | 0.03 | 0.16 | -0 | 0.09 | 0.02 | 0.04 | |
| Change in Accounts Receivable | - | - | 0.05 | 1.44 | -0.51 | 0.15 | |
| Change in Accounts Payable | -1.68 | 0.9 | -1.64 | 2.29 | 0.04 | 0.53 | |
| Change in Unearned Revenue | 0.09 | -0.72 | -3.13 | -14.72 | 0.35 | -3.35 | |
| Change in Other Net Operating Assets | 6.51 | 0.45 | 3.39 | -4.54 | -0.59 | 2.93 | |
| Operating Cash Flow | -113.37 | -75.79 | -86.69 | -69.13 | -50.91 | -36.71 | |
| Capital Expenditures | -3.39 | -2.77 | -11.54 | -9.11 | -1 | -3.2 | |
| Investment in Securities | -312.79 | 118.49 | -5.51 | -163.57 | - | - | |
| Investing Cash Flow | -316.18 | 115.72 | -17.05 | -172.68 | -1 | -3.2 | |
| Issuance of Common Stock | 341.41 | 156.83 | 3.55 | 118.09 | 206.52 | 0.08 | |
| Other Financing Activities | - | - | -0.47 | - | -3.14 | -2.27 | |
| Financing Cash Flow | 341.41 | 156.83 | 3.09 | 118.09 | 278.98 | -2.2 | |
| Net Cash Flow | -88.14 | 196.76 | -100.65 | -123.73 | 227.07 | -42.11 | |
| Free Cash Flow | -116.76 | -78.56 | -98.22 | -78.24 | -51.91 | -39.91 | |
| Free Cash Flow Margin | -686811.76% | -379.11% | -3139.05% | -433.77% | -381.35% | -571.34% | |
| Free Cash Flow Per Share | -2.30 | -2.01 | -3.04 | -2.82 | -8.07 | -7.76 | |
| Levered Free Cash Flow | -68.6 | -46.48 | -59.7 | -41 | -29.23 | -20.21 | |
| Unlevered Free Cash Flow | -68.6 | -46.48 | -59.7 | -41 | -29.23 | -20.21 | |
| Change in Net Working Capital | -9.05 | -1.33 | 0.49 | 4.21 | -0.72 | -4.35 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.